Doctor Details

Dr. Melissa Teo specialises in treating cancers of the colon and rectum, lower gastrointestinal cancers, and surgical oncology, and has treated complex abdominal, pelvic, and peritoneal cases. She has experience in the management of peritoneal disease (Cytoreductive Hyperthermic Intraperitoneal Chemotherapy (CRS HIPEC)).

She is also the president of the Asian Peritoneal Surface Malignancy Group (ASPMG). She is a senior consultant and the former head of the division of surgical oncology at the National Cancer Center Singapore (NCCS) from 2015 to 2019. She started and headed NCCS’Centerof Peritoneal and Pelvic Disease.

Currently, she continues as a visiting consultant in the surgical oncology division at NCCS. Dr Teo completed her general surgical training in Singapore and was awarded the Health Manpower Development Plan scholarships by the Ministry of Health (MOH) for 2 fellowships in surgical oncology and colorectal surgery, where she enhanced her skills in complex abdominal and pelvic surgery.

At NCCS, she worked together leading the sarcoma and melanoma team and was a member of the gastrointestinal tract workgroup for the NCCS cancer service line. She was the chairperson for faculty affairs and professional development in the surgery academic clinical program and was also the chairperson for the new NCCS building committee.

She was also the director of strategic initiatives in the oncology academic clinical program. At the same time, she pursued clinical excellence, as well as clinical research and teaching. She was the principal investigator of more than 43 institutional review boards and has authored more than 250 peer-reviewed publications and 6 book chapters.

Dr Teo has performed an average of 400 surgeries a year and has performed more than 10,000 gastroscopies and colonoscopies. She has been practising medicine for more than 20 years. She is a member of the Singapore Society of Oncology. She also sits on the Singapore Cancer Network sarcoma guideline committee and was a member of the MOH technology advisory committee.

She continues to be an adjunct professor at DUKE-NUS Medical School.